Latest profit margin
Scinai Immunotherapeutics Profit margin
Direct answer
Scinai Immunotherapeutics's profit margin is -174.78%.
The verified market snapshot reports -174.78%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 1, 2026.
Get free Scinai Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Profit margin
- -174.78%
Explore related company data
View Scinai Immunotherapeutics's market capitalizationView Scinai Immunotherapeutics's p/e ratioView Scinai Immunotherapeutics's price-to-book ratioView Scinai Immunotherapeutics's return on equityView Scinai Immunotherapeutics's 52-week price rangeView Scinai Immunotherapeutics's revenue growthView Scinai Immunotherapeutics's debt-to-equity ratioView all Scinai Immunotherapeutics key metricsReturn to Scinai Immunotherapeutics profile